Solactis Overview

  • Founded
  • 2013
  • Status
  • Acquired/​Merged
  • Employees
  • 3
  • Latest Deal Type
  • M&A

Solactis General Information


Manufacturer of a bio-functional ingredient designed to improve colon and digestive functions. The company's product, Galactofructose, reduces transit time in colon, improves digestive discomfort as well as reinforces immune defences in the digestive system, enabling users to get relief from gastric and other stomach pains and discomfort.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Other Industries
Drug Delivery
Parent Company
The Greentech group
Primary Office
  • Domaine de Vilvert - Bâtiment 325
  • 78352 Jouy-en-Josas
  • France
+33 01 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Solactis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 15-Apr-2021 Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view Solactis’s complete valuation and funding history, request access »

Solactis Patents

Solactis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2013530701-A Galactofructose prebiotic effects Withdrawn 22-Jun-2010 00000000000
FR-2961378-A1 Prebiotic effect of oligosaccharides Pending 22-Jun-2010 00000000000
EP-2584919-A1 Prebiotic effect of galactofructose Ceased 22-Jun-2010 A61K31/7016

Solactis Executive Team (1)

Name Title Board Seat Contact Info
Pascal Ronfard President
To view Solactis’s complete executive team members history, request access »

Solactis Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Solactis Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Agoranov Accelerator/Incubator Minority 000 0000 000000 0
To view Solactis’s complete investors history, request access »